ZHEJIANG TIANYU PHARMACEUTICAL CO., LTD.

News Zhejiang Tianyu Pharmaceutical Co., Ltd.

Equities

300702

CNE1000034X1

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-13 pm EDT			5-day change	1st Jan Change
20.83 ^CNY	+3.43%		+3.58%	-4.05%

May. 06	China Approves Tianyu Pharma's Heart Medication	MT
Apr. 25	Zhejiang Tianyu Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

China Approves Tianyu Pharma's Heart Medication	May. 06	MT
Zhejiang Tianyu Pharmaceutical Co., Ltd. Announces Profit Distribution Proposal for 2023	Apr. 26	CI
Zhejiang Tianyu Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Zhejiang Tianyu Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 25	CI
Tranche Update on Zhejiang Tianyu Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on January 24, 2024.	Apr. 02	CI
Zhaoxin Liaowang No. 1 Private Securities Investment Fund managed by Jiangsu Zhaoxin Private Fund Management Co., Ltd. entered into a share transfer agreement to acquire 6.19% stake in Zhejiang Tianyu Pharmaceutical Co., Ltd. from Ganzhou Zhenhan Venture Capital Co., Ltd. for CNY 310 million.	Mar. 19	CI
Zhejiang Tianyu Pharmaceutical Co., Ltd. announces an Equity Buyback for CNY 50 million worth of its shares.	Jan. 24	CI
Zhejiang Tianyu Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	Jan. 23	CI
Tianyu Pharmaceutical Unit Passes US FDA's On-Site Inspection	Nov. 22	MT
Tianyu Pharma Unit Passes US FDA On-Site Inspection	Nov. 20	MT
Zhejiang Tianyu Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
Zhejiang Tianyu Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-28	CI
Zhuhai Rundu Pharma Gets Supplementary Application Approval For Hypertension Drug	23-07-26	MT
Raw Drug Material of Tianyu Pharma's Unit Passes Regulatory Evaluation	23-06-16	MT
Zhejiang Tianyu Pharmaceutical Co., Ltd. announced that it expects to receive CNY 1.4 billion in funding	23-06-15	CI
Zhejiang Tianyu Pharmaceutical Co., Ltd. Announces Management Changes	23-05-23	CI
Tianyu Pharmaceutical Unit Gets Approval to Market Hypertension Drug in China	23-05-09	MT
Zhejiang Tianyu Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-26	CI
Zhejiang Tianyu Pharma Unit Gets Marketing Approval For Losartan Potassium Tablets	23-02-20	MT
Tranche Update on Zhejiang Tianyu Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 30, 2022.	22-12-15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Zhejiang Tianyu Pharmaceutical Co., Ltd.

Equities

300702

CNE1000034X1

Summary

Filters